Cochrane Review Group
Skin
74 systematic reviews in Skin ask 1,886 questions. 28.7% have no studies to answer them, 17.3% rest on very low certainty evidence and 24.1% reach moderate or high certainty.
Reviews
74
Questions
1,886
current versions
No studies
28.7%
Moderate or high
24.1%
No studies 542 · 28.7%Ungraded 130 · 6.9%Very low 326 · 17.3%Low 434 · 23%Moderate 348 · 18.5%High 106 · 5.6%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Thinnest evidence
All no studies and very low questions| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Prednisone plus azathioprine vs prednisone Disease control (at 6 months) · bullous pemphigoid Interventions for bullous pemphigoid (2023) · Cochrane | RR 0.93 [0.52, 1.66] | 1 study · 67 participants | Very low |
Prednisone plus azathioprine vs prednisone Mortality (at 6 months) · bullous pemphigoid Interventions for bullous pemphigoid (2023) · Cochrane | RR 1.03 [0.35, 3.06] | 1 study · 67 participants | Very low |
Prednisone plus azathioprine vs prednisone Quality of life ‐ not measured · bullous pemphigoid Interventions for bullous pemphigoid (2023) · Cochrane | no estimate extracted | NR | No studies |
Prednisone plus azathioprine vs prednisone Adverse events · bullous pemphigoid Interventions for bullous pemphigoid (2023) · Cochrane | no estimate extracted | NR | Very low |
Nicotinamide plus tetracycline vs prednisone Disease control: complete response at 8 weeks: excluding dropouts · bullous pemphigoid Interventions for bullous pemphigoid (2023) · Cochrane | RR 2.5 [0.37, 16.89] | 1 study · 18 participants | Very low |
Nicotinamide plus tetracycline vs prednisone Mortality at 6 months · bullous pemphigoid Interventions for bullous pemphigoid (2023) · Cochrane | RR 0.18 [0.01, 3.85] | 1 study · 18 participants | Very low |
Nicotinamide plus tetracycline vs prednisone Quality of life ‐ not measured · bullous pemphigoid Interventions for bullous pemphigoid (2023) · Cochrane | no estimate extracted | NR | No studies |
Nicotinamide plus tetracycline vs prednisone Adverse events at 1 year · bullous pemphigoid Interventions for bullous pemphigoid (2023) · Cochrane | no estimate extracted | NR | Very low |
Methylprednisolone plus azathioprine vs methylprednisolone plus dapsone Disease control (time when steroid could be discontinued) · bullous pemphigoid Interventions for bullous pemphigoid (2023) · Cochrane | no estimate extracted | 1 study · 54 participants | Very low |
Methylprednisolone plus azathioprine vs methylprednisolone plus dapsone Mortality at 1 year · bullous pemphigoid Interventions for bullous pemphigoid (2023) · Cochrane | RR 0.33 [0.04, 3.01] | 1 study · 54 participants | Very low |
Methylprednisolone plus azathioprine vs methylprednisolone plus dapsone Quality of life ‐ not measured · bullous pemphigoid Interventions for bullous pemphigoid (2023) · Cochrane | no estimate extracted | NR | No studies |
Methylprednisolone plus azathioprine vs methylprednisolone plus dapsone Adverse events at 1 year · bullous pemphigoid Interventions for bullous pemphigoid (2023) · Cochrane | no estimate extracted | NR | Very low |
Reviews 74
Interventions for bullous pemphigoid
CochraneSoF table
24 questions
Neoadjuvant treatment for stage III and IV cutaneous melanoma
CochraneSoF table
35 questions
Treatments for alopecia areata: a network meta‐analysis
CochraneSoF table
48 questions
Systemic interventions for treatment of Stevens‐Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome
CochraneSoF table
50 questions
Strategies for using topical corticosteroids in children and adults with eczema
CochraneSoF table
28 questions
Skin care interventions in infants for preventing eczema and food allergy
CochraneSoF table
8 questions
Interventions for cutaneous disease in systemic lupus erythematosus
CochraneSoF table
42 questions
Botulinum toxin type A for facial wrinkles
CochraneSoF table
30 questions
Interventions for bacterial folliculitis and boils (furuncles and carbuncles)
CochraneSoF table
35 questions
Phototherapy for atopic eczema
CochraneSoF table
20 questions
Interventions for basal cell carcinoma of the skin
CochraneSoF table
24 questions
Interventions for American cutaneous and mucocutaneous leishmaniasis
CochraneSoF table
21 questions
Interventions for mycosis fungoides
CochraneSoF table
20 questions
Topical benzoyl peroxide for acne
CochraneSoF table
15 questions
Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha‐hydroxy acid) for acne
CochraneSoF table
40 questions
Hygiene and emollient interventions for maintaining skin integrity in older people in hospital and residential care settings
CochraneSoF table
7 questions
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
CochraneSoF table
38 questions
Interventions for chronic palmoplantar pustulosis
CochraneSoF table
84 questions
Indoor salt water baths followed by artificial ultraviolet B light for chronic plaque psoriasis
CochraneSoF table
2 questions
Topical and device‐based treatments for fungal infections of the toenails
CochraneSoF table
24 questions
Interventions for chronic pruritus of unknown origin
CochraneSoF table
18 questions
Systemic treatments for eczema: a network meta‐analysis
CochraneSoF table
35 questions
Interventions to reduce Staphylococcus aureus in the management of eczema
CochraneSoF table
21 questions
Interventions for hand eczema
CochraneSoF table
34 questions
Interventions for morphea
CochraneSoF table
16 questions